EU health spending falls for first time since 1975
In 2010, health spending across the European Union (EU) declined for the first time since 1975, and growth in pharmaceutical expenditures ground to a halt, say new figures.
Read MoreAuthor: Lynne Taylor
Drug shortages not causing patients harm, says Minister
Shortages of prescription medicines can cause inconvenience and distress to NHS patients, but the government is not aware of any examples of people suffering actual harm, Health Minister Earl Howe has said.
Read MoreEuro sales of Alzheimer’s drugs to soar 15% a year to 2019: study
The European market for drugs to treat Alzheimer’s disease (AD) is set to grow from a value of $1.80 billion in 2012 to $4.78 billion by 2019, increasing at a compound annual growth rate (CAGR) of 15.1% during the period, according to new forecasts.
Read MoreIndia needs market-based drug pricing, govt urged
A leading industry group has urged the India government to abandon cost-based drug pricing and introduce a market-based pricing policy, which would, it says, improve affordability and availability of medicines, and encourage innovation, competition and growth.
Read MoreGovt urged over access to rare-disease drugs
People with rarer diseases have problems accessing effective new treatments, so plans for earlier-access schemes for drugs to treat these conditions should be considered, the government has been told.
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
